Literature DB >> 22274833

Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?

Julia Hentschel1, Gabriele Riesener, Heike Nelle, Manfred Stuhrmann, Anja Schöner, Olaf Sommerburg, Eva Fritzsching, Marcus A Mall, Ferdinand von Eggeling, Jochen G Mainz.   

Abstract

UNLABELLED: We report on a 6-month-old premature boy from consanguineous parents. He presented with respiratory distress, necrotizing enterocolitis and hyperbilirubinemia shortly after birth. Persisting respiratory symptoms and failure to thrive prompted cystic fibrosis diagnostics, which showed the lack of wild-type signal for the mutation R347P suggesting a homozygous deletion or an alteration different from the known mutation at this position. Sequencing of this region revealed the homozygous substitution 1175 T > A (HGVS: c.1043 T > A) in exon 7 resulting in the homozygous amino acid change M348K. This mutation has never been reported in homozygosity before. Computational analysis tools classified M348K as 'presumably disease causing.' In our patient, sweat testing and electrophysiological assessment of CFTR function in native rectal epithelium demonstrated normal Cl(-) secretion.
CONCLUSION: We assume that the homozygous alteration M348K is a harmless variant rather than a CF-causing mutation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274833     DOI: 10.1007/s00431-012-1672-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

2.  PMUT: a web-based tool for the annotation of pathological mutations on proteins.

Authors:  Carles Ferrer-Costa; Josep Lluis Gelpí; Leire Zamakola; Ivan Parraga; Xavier de la Cruz; Modesto Orozco
Journal:  Bioinformatics       Date:  2005-05-06       Impact factor: 6.937

3.  Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism.

Authors:  Maria Rosaria D'Apice; Stefano Gambardella; Silvia Russo; Vincenzina Lucidi; Anna Maria Nardone; Adalgisa Pietropolli; Giuseppe Novelli
Journal:  Prenat Diagn       Date:  2004-12-15       Impact factor: 3.050

4.  Identification of three novel cystic fibrosis mutations in a sample of Italian cystic fibrosis patients.

Authors:  M P Audrézet; G Novelli; B Mercier; F Sangiuolo; P Maceratesi; C Férec; B Dallapiccola
Journal:  Hum Hered       Date:  1993 Sep-Oct       Impact factor: 0.444

5.  Effect of genistein on native epithelial tissue from normal individuals and CF patients and on ion channels expressed in Xenopus oocytes.

Authors:  M Mall; A Wissner; H H Seydewitz; M Hübner; J Kuehr; M Brandis; R Greger; K Kunzelmann
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

6.  Description of a symptomless cystic fibrosis L346P/M348K compound heterozygous Cypriot individual.

Authors:  C C Deltas; K Boteva; A Georgiou; E Papageorgiou; C Georgiou
Journal:  Mol Cell Probes       Date:  1996-08       Impact factor: 2.365

7.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

Review 8.  Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis.

Authors:  Marcus Mall; Stephanie Hirtz; Tanja Gonska; Karl Kunzelmann
Journal:  J Cyst Fibros       Date:  2004-08       Impact factor: 5.482

Review 9.  Structure and function of the CFTR chloride channel.

Authors:  D N Sheppard; M J Welsh
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

10.  The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients.

Authors:  Eva K Roth; Stephanie Hirtz; Julia Duerr; Daniel Wenning; Irmgard Eichler; Hans H Seydewitz; Margarida D Amaral; Marcus A Mall
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

View more
  1 in total

1.  Incidental Finding of a Homozygous p.M348K Asymptomatic Italian Patient Confirms the Many Faces of Cystic Fibrosis.

Authors:  Rossana Molinario; Sara Palumbo; Paola Concolino; Sandro Rocchetti; Roberta Rizza; Giovanni Luca Scaglione; Angelo Minucci; Ettore Capoluongo
Journal:  Case Rep Genet       Date:  2015-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.